The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation

Bone Marrow Transplantation

Volumn 24, Issue 12, 1999, Pages 1315-1322

  McCarthy, A J ^a   Kingman, H M ^a   Kelly, C ^a   Taylor, G S ^b   Caul, E O ^b   Grier, D ^a   Moppett, J ^a   Foot, A B M ^a   Cornish, J ^a   Oakhill, A ^a   Steward, C G ^a   Pamphilon, D H ^a   Marks, D I ^a  

^a BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Allogeneic bone marrow transplantation; Respiratory syncytial virus; Ribavirin; RSV genotyping

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; PREDNISONE; RIBAVIRIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BETA THALASSEMIA; BONE MARROW SUPPRESSION; BRAIN HEMORRHAGE; CHRONIC MYELOID LEUKEMIA; DEATH; FANCONI ANEMIA; GENOTYPE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; LOWER RESPIRATORY TRACT INFECTION; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0033379858     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702078     Document Type: Article

References (26)

1. Hall CB, Powell KR, MacDonald NE et al. Respiratory syncytial viral infection in children with compromised immune function. New Engl J Med 1986; 315: 77-81.
2. Hertz MI, Englund JA, Snover D et al. Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine 1989; 68: 269-281.
3. Arola M, Ruuskanen O, Ziegler T, Salmi TT. Respiratory virus infections during anticancer treatment in children. Ped Inf Dis J 1995; 14: 690-694.
4. Vettenranta K, Ukkonen P, Saarinen UM. RSV infection complicating the therapy of pediatric malignancies: report of six cases. Meet Ped Onc 1996; 26: 261-263.
5. Hull CB, Walsh E, Long C, Schnabel C. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 1991; 163: 693-698.
6. Anderson LJ, Hierholzer JC, Tsou C et al. Antigenic characterisation of respiratory syncytial virus strains with monoclonal antibodies. J Inf Dis 1985; 151: 626-633.
7. Mufson MA, Orvell C, Rafnar B, Norrby E. Two distinct subtypes of respiratory syncitial virus. J Gen Virol 1985; 66: 2111-2124.
8. Johnson R, Spriggs MK, Olmsted RA, Collins PL. The G glycoprotein of human respiratory syncitial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc Natl Acad Sci USA 1987; 84: 5625-5629.
9. Cane PA, Pringle CR. Respiratory syncytial virus heterogeneity during an epidemic: analysis by limited nucleotide sequencing (SH gene) and restriction mapping (N gene). J Gen Virol 1991: 72: 349-357.
10. Cane PA, Pringle CR. Molecular epidemiology of respiratory syncytial virus: rapid identification of subgroup A lineages. J Virol Meth 1992; 40: 297-306.
11. Hall CB, Walsh EE, Schnabel KC et al. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis 1990; 162: 1283-1290.
12. Fletcher JN, Smyth LS. Thomas HM et al. Respiratory syncytial virus genotypes and disease severity among children in hospital. Arch Dis Child 1997; 77: 508-511.
13. Whimbey E, Champlin RE, Couch RB et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996; 22: 778-782.
14. Sparrelid E, Ljungman P, Ekelof-Andstrom E et al. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant 1997; 19: 905-908.
15. Krinzman S, Basgoz N, Kradin R et al. Respiratory syncytial virus-associated infections in adult recipients of solid organ transplants. J Heart Lung Transplant 1998; 17: 202-210.
16. McColl MD, Corser RB, Bremmer J, Chopra R. Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration aerosolised ribavirin. Bone Marow Transplant 1998; 21: 423-425.
17. Ljungman P, Gleaves CA, Meyers JD. Respiratory virus infections in immunocompromised patients. Bone Marrow Transplant 1989; 4: 34-40.
18. Englund JA, Piedra PA, Jewell A et al. Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. J Clin Micro 1996; 34: 1649-1653.
19. Cane PA, Matthews DA, Pringle CR. Analysis of respiratory syncitial virus strain variation in successive epidemics in one city. J Clin Micro 1994; 32: 1-4.
20. Peret TC, Hall CB, Schnabel KC et al. Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol 1998; 79: 2221-2229.
21. Law BJ, Wang EEL, MacDonald N et al. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigator collaborative network in infections in Canada (PICNIC) RSV database. Pediatrics 1997; 99: E7.
22. Randolph AG, Wang EE. Ribavirin for RSV lower respiratory tract infections. Arch Paed Adoles Med 1996; 150: 942-947.
23. Conrad DA, Christenson JC, Waner JL, Marks MI. Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemic. Ped Infect Dis J 1987; 6: 152-158.
24. Hall CB, McBride JT, Walsh EE. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection: a randomized double-blind study. New Engl J Med 1983; 308: 1443-1447.
25. DeVincenzo JP, Leombruno D. Soiffer RJ, Siber GR. Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation. Bone Marrow Transplant 1996; 17: 1051-1056.
26. Boom R. Sol CJA, Salimans MMM et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28: 495-503.